Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2023-04-13 Major Shareholding Noti…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of regulatory filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company, or when there is a change in such holdings. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ).
2023-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to report insider transactions, such as the exercise of stock options by an executive (in this case, Song Hong-gi of Cellumed). This falls under the category of Director's Dealing (DIRS).
2023-04-12 Korean
증권발행결과(자율공시)(제26회차 CB)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the result of a securities issuance (specifically a convertible bond, '제26회차 CB'). It details the issuance amount, payment date, and the nature of the security. This falls under the category of capital and financing updates, specifically related to the issuance of debt instruments.
2023-04-05 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for the company Cellumed. It details the outcomes of various agenda items, including the approval of financial statements, election of directors, and changes to business purposes. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it provides the official record of shareholder votes and meeting outcomes.
2023-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the names of the individuals, their roles, and the reasons for their departure or appointment. This falls directly under the category of Board/Management Information.
2023-03-30 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) by Cellumed Co., Ltd. It details the decision to issue convertible bonds (전환사채권 발행결정), including terms, interest rates, conversion prices, and the use of proceeds. This is a standard regulatory filing for capital raising activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2023-03-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.